NCT05402878

Brief Summary

Rationale: Recently, two prospective multicenter RCT reported a potential beneficial effect of endovascular thrombectomy (EVT) in patients with an acute symptomatic basilar artery occlusion (BAO). However, the high rate of crossover in BEST study and the long-term of recruitment in BASICS study influenced the validity of the results. Objective: To assess the outcomes and prognostic factors of recanalization therapy in patients with BAO, caused by a CTA/MRA/DSA confirmed occlusion of the basilar artery. Study design: This is a prospective observational study. Study population: Patients with acute ischemic stroke and a confirmed basilar artery occlusion by CTA/MRA/DSA. Main study parameters/outcomes: Favorable outcome at day 90 defined as a modified Rankin Score (mRS - functional scale) of 0-3. The estimate will be adjusted for the known prognostic variables age, time from onset to treatment, stroke severity (NIHSS), PC ASPECT and collateral flow and adjusted and unadjusted estimates with corresponding 95% confidence intervals will be reported.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2021

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

May 26, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 2, 2022

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

July 26, 2022

Status Verified

July 1, 2022

Enrollment Period

2.4 years

First QC Date

May 26, 2022

Last Update Submit

July 25, 2022

Conditions

Keywords

BASILAR ARTERY OCCLUSIONRECANALISATION THERAPY

Outcome Measures

Primary Outcomes (1)

  • favourable outcome

    a modified Rankin Score of 0-3

    90 (± 14 days) after procedure

Secondary Outcomes (6)

  • good outcome

    90 (± 14 days) after procedure

  • mortality

    90 (± 14 days) after procedure

  • Dichotomized mRS score

    90 (± 14 days) after procedure

  • Symptomatic intracerebral hemorrhage (sICH)

    within 72 hours after procedure

  • Any intracerebral hemorrhage

    within 72 hours after procedure

  • +1 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients who were acute ischemic stroke due to basilar artery occlusion admitted People 115 Hospital and treated recanalisation therapies : intravenous tPA, bridging tPA and thrombectomy or thrombectomy alone.

You may qualify if:

  • Symptoms and signs compatible with ischemia in the basilar artery territory.
  • Basilar artery occlusion (BAO) confirmed by CTA or MRA or DSA.
  • Age 18 years or older
  • Patients were treated with one of these among therapies IVT alone, bridging IVT and thrombectomy or thrombectomy alone..

You may not qualify if:

  • Patients did not agree to enroll.
  • High-density lesion consistent with hemorrhage of any degree
  • Significant cerebellar mass effect or acute hydrocephalus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

People 115 Hospital

Ho Chi Minh City, Ho Chi Minh City, 70000, Vietnam

RECRUITING

Study Officials

  • Huy Thang Nguyen, Professor

    People 115 Hospital

    STUDY DIRECTOR

Central Study Contacts

Huy Thang Nguyen

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Months
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Investigator

Study Record Dates

First Submitted

May 26, 2022

First Posted

June 2, 2022

Study Start

August 1, 2021

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

July 26, 2022

Record last verified: 2022-07

Locations